Smokers With Colon Cancer Face High Recur...( -- Robert Preidt ...),Health
Navigation Links
Smokers With Colon Cancer Face High Recurrence Risk
Date:6/2/2008
-- Robert Preidt
SOURCE: American Society of Clinical Oncology, news release, May 29, 2008
'/>"/>
| Copyright©2008 ScoutNews,LLC. All rights reserved |
Related medicine news :
1. Smokers with advanced colon cancer may face higher odds of disease recurrence
2. PA State Health Officials Encourage Smokers to Quit on World No Tobacco Day
3. Mayo Clinic researchers find common gene disorder doubles risk of lung cancer, even among nonsmokers
4. Nicotine Replacement Therapy Is Safe, Effective and Can Help Reverse Mental Acuity Deficits in Smokers Who Are Quitting, Including Commercial and Private Pilots
5. New Guidelines Show Smokers Have More Tools to Quit Than Ever, But Elected Officials Must Do More to Help
6. New Evidence Provides Clinicians With Better Tools to Help Smokers Quit
7. Smokers have a 41 percent higher risk of suffering depression
8. Alzheimers Starts Earlier for Heavy Drinkers, Smokers
9. Better-Educated Smokers More Likely to Quit After Seeing Ads
10. Genetic variations raise lung cancer risk for smokers and ex-smokers
11. Smokers with lung disease need more than brief intervention
Post Your Comments:
Related Image:
 Smokers With Colon Cancer Face High Recurrence Risk |
(Date:12/2/2008)...Dec. 2 Smile Reminder, the nation,...vice, unveiled the latest in industry,technology ... a digital tool,for capturing and distributing vi...eo patient testimonials onto popular platforms suc...s new tool provides doctors with an effective,bus...
(Date:12/2/2008)...oed for Tuesday, December 2, 2008 at 3 pm CST)--Ra...dical University of South Carolina in Charleston, ...f cancer from exposure to radiation during compute...verstated and that new estimates are several times... MUSC researchers presented their findings at the ...
(Date:12/2/2008)...elationships establish special bonds between partn...nent partnerships, and ultimately, the start of fa...rs place too much emotional weight on their relati...uate their self-worth solely based on the outcomes...hologists term as relationship-contingent self-est...
(Date:12/2/2008)...Dec. 2 In an open lette...ation of Homes and Services for the Aging (AAHSA) ...ways that the Obama administration can make both s... the way America cares for its most vulnerable peo...xpand the Nation,s Work Force: Create Jobs in Agin...
Breaking Medicine News(10 mins):Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 3Health News:Radiological Society of North America research: Cancer risk from cardiac CT overstated 2Health News:Too much commitment may be unhealthy for relationships, UH psychology professor says 2[0] Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients[0] Radiological Society of North America research: Cancer risk from cardiac CT overstated[0] Too much commitment may be unhealthy for relationships, UH psychology professor says[0] Minnix Offers Obama Path for Transforming Aging Services
...es, hospitals, nursing homes, Diagnostic centres w...the minimum standards specified by law –// accordi...at has been finalised by the Health Ministry and i...val. The proposed law will apply to all recognise...
...f Philippines, proposes to link-up with tour opera...tment and check-ups with rest and recreation in// ... forum ,Cynthia Carrion, the assistant secretary f...ent of Tourism said, "We are now [coordinating] wi...
...he 11th Keio Medical Science Award from Keio Unive...of Molecular Biophysics and Biochemistry// at Yale...ve symposium conducted by the University on Novemb...rs in recognition of their outstanding achievement...
...to support the Public Health Foundation of India (...ublic Health in India. PHFI is an autonomous// bod...as one-time grant upto Rs. 65 crore only to the in... initially proposes to set up two schools. The loc...
Other Medicine News:Health News:Yale Scientist Received Medical Science Prize From Keio University 2(Date:12/1/2008)...e-USNewswire/ -- New research has found that the a...ography (CT) scanner in an emergency room can sign...o receive a potentially life-saving treatment. Res...l Center (NSMC)-Salem Hospital in Salem, Mass., wi... Radiological Society of North America (RSNA). , ...
(Date:12/1/2008)...ire/ -- TargeGen has announced that an oral,prese...r, US-based clinical,trial of TG101348 in myelopr...,the 2008 American Society of Hematology (ASH) Me...as follows:, Title: A Phase I S... JAK2-Selective Inhibitor, in Patie...
(Date:12/1/2008)...tasia Treated With ENB-0040 at Children,s Hospital...NTREAL, Dec. 1 Enobia Pharma, an e...ping novel therapeutics for serious bone disorders... its clinical program for hypophosphatasia was dos...rapy (ERT) with ENB-0040 for the treatment of this...
(Date:12/1/2008).... 1 Genaera Corporation...subjects has begun in study MSI-1436C-102 (Study 1... trodusquemine (MSI-1436) in overweight and obese ...for the treatment of type 2 diabetes and obesity w...insulin and leptin pathways through the highly sel...
Breaking Medicine Technology:Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 1Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 2Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 3Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 4Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 5A reputation for innovation 4796 1A reputation for innovation 4796 2Governor Rendell Announces Resignation of Health Secretary Dr Calvin Johnson 26201 1Governor Rendell Announces Resignation of Health Secretary Dr Calvin Johnson 26201 2Online Health Information Category Grows at Rate Four Times Faster Than Total Internet 26196 1Online Health Information Category Grows at Rate Four Times Faster Than Total Internet 26196 2Online Health Information Category Grows at Rate Four Times Faster Than Total Internet 26196 3Online Health Information Category Grows at Rate Four Times Faster Than Total Internet 26196 4[0] Portable CT Increases Chance of Stroke Survival and Recovery[0] TargeGen Affiliates Scheduled for Oral Presentation of Interim Clinical Trial Data at 2008 ASH Meeting in San Francisco for TG101348, a Potent, Selective, Oral JAK2 Inhibitor in Myeloproliferative Disease Patients[0] Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease[0] Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics
...22, 2007 /PRNewswire/ -- Principal,investigators f...roliferative for Restenosis) trial, the pivotal st...luting coronary stent,presented today the clinica...investigators confirmed that the study failed to m...ed this conclusion in a,press release on Monday, M...
... FDA Approval of SEROQUEL XR--, WILMINGTON, Del., ... today announced that two analyses from a large-sc...EL XR(TM) (quetiapine,fumarate) Extended-Release T... schizophrenia in adult patients, were presented t...tric Association,(APA). These analyses from the cl...
Other Medicine Technology:Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial,Results at EuroPCR 2007 2Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial,Results at EuroPCR 2007 3New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 2New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 3New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 4New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 5New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 6New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 7New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 8New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 9Wipe + Wick
Ophthalmic Ring
Lacrimal Cannula, Straight, Stepped DownSize: 19g x 1-1/2".
PremierEdge™ Slit Knives.
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |